Ascendis Pharma A/S <ASND.O>: H.C. Wainwright cuts target price to $344 from $345
ASND•Related News
BridgeBio publishes DISCOVER-ATTR digital registry presentation on ATTR-CM data integration
BBIO•
Nasdaq Trade Halt <GMHS.O> Volatility Trading Pause at 11:33 AM
GMHS•
California utility shares tumble as wildfire bill fails to ease liability risks
PCG•
Gilat sets executive pay policy with CEO monthly base salary cap of NIS 170,000
GILT•
Software stocks to mark biggest two-month gain since November 2002
QQQ•